Company / SG&A Expense
Natera, Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$1.2B
FY2025
5-year range
$303.6M / $1.2B
FY2021-FY2025
Trend
+39.9%
vs FY2024
Sector context
#41 of 158
Health Care
What the data says
At $1.2B, Natera, Inc.'s sg&a expense ranks #118 of 158 in the Health Care sector. SG&A Expense has increased for 3 consecutive years, from $304M in FY2022 to $1.2B in FY2025.
Based on SEC 10-K filings.
$1.2B in FY2025 with a 5-year CAGR of +50.0%.
Increased from $618M to $1.2B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +57.1%
- 5-Year CAGR
- +50.0%
- 10-Year CAGR
- -
Sector benchmark
#118 of 158 in Health CareTop 74% of 158This company $1.2B Sector average $175.9B
▼
-99.3% below sector average
Key checks
Key Insights
- Natera, Inc.'s sg&a expense has grown for 3 consecutive years.
- 5-year CAGR of +50.0%, indicating consistent growth.
- In FY2025, sg&a expense increased 39.9% year-over-year.
- Ranks #41 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | +39.9% |
| FY2024 | $841.3M | +36.1% |
| FY2023 | $618.3M | +103.6% |
| FY2022 | $303.6M | -40.6% |
| FY2021 | $511.0M | +230.0% |
| FY2020 | $154.9M | -0.3% |
| FY2019 | $155.3M | +0.3% |
| FY2018 | $154.9M | -0.3% |
| FY2017 | $155.3M | +14.1% |
| FY2016 | $136.1M | +24.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026